PSTV
Plus Therapeutics Inc
NASDAQ: PSTV · HEALTHCARE · BIOTECHNOLOGY
$3.63
-3.46% today
Updated 2026-07-29
Market cap
$26.85M
P/E ratio
0.19
P/S ratio
5.18x
EPS (TTM)
$20.45
Dividend yield
—
52W range
$3 – $24
Volume
0.2M
Plus Therapeutics Inc (PSTV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.63
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.19x (capped 25x) · Margin: -230.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.